4//SEC Filing
Stelmakh Edward 4
Accession 0001628280-24-052522
CIK 0001448431other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:00 PM ET
Size
7.4 KB
Accession
0001628280-24-052522
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Stelmakh Edward
CFO/COO
Transactions
- Award
Common Stock
2024-12-23+41,408→ 97,295 total - Award
Stock Option
2024-12-23+77,742→ 77,742 totalExercise: $4.83From: 2025-12-23Exp: 2027-12-23→ Common Stock (77,742 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001887046
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:00 PM ET
- Size
- 7.4 KB